Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-759.93%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.62Close
$ 1.14 - $ 4.8 52-Week Range
Ticker Information
Ticker
AUTLCompany Name
AUTOLUS THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAUTOLUS THERAPEUTICS PLC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AUTL - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -227.48M | -759.93% | $ 29.93M |
| 3/31/2025 | $ -221.38M | -2456.76% | $ 9.01M |
| 12/31/2024 | $ -197.41M | -1950.67% | $ 10.12M |
| 9/30/2024 | $ -172.59M | -1710.36% | $ 10.09M |
| 6/30/2024 | $ -148.73M | -1416.89% | $ 10.5M |
| 3/31/2024 | $ -146.22M | -1392.99% | $ 10.5M |
| 12/31/2023 | $ -152.71M | -8993.64% | $ 1.7M |
| 9/30/2023 | $ -150.82M | -2730.83% | $ 5.52M |
| 6/30/2023 | $ -151.71M | -2026.58% | $ 7.49M |
| 3/31/2023 | $ -155.02M | -2070.85% | $ 7.49M |
Key Performance Insights, Last 5 Years
- AUTOLUS THERAPEUTICS PLC's latest trailing twelve months (TTM) EBITDA % stands at -9709.38%.
- Over the past 5 years, AUTOLUS THERAPEUTICS PLC's average EBITDA % has been -5883.09%.
- The median EBITDA % for AUTOLUS THERAPEUTICS PLC during this period was -4119.72%
- AUTOLUS THERAPEUTICS PLC reached its highest EBITDA % over the past 5 years at -759.93%.
- The lowest EBITDA % recorded by AUTOLUS THERAPEUTICS PLC in the same timeframe -28598.63%
AUTOLUS THERAPEUTICS PLC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for AUTOLUS THERAPEUTICS PLC is calculated as follows: EBITDA [ $ -157.29M ] / Revenues [ $ 1.62M ]
(=) EBITDA % [ -9709.38% ] AUTL - EBITDA Margin, Last 5 years
-28598.63%
Minimum
Jun 30, 2022
-759.93%
Maximum
Jun 30, 2025
-5883.09%
Average
-4119.72%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |